EE60 An Economic Evaluation of Introducing Ferric Carboxymaltose for the Treatment of Iron Deficiency in Patients With Heart Failure From the Perspective of Healthcare Payers in Sweden, Germany, France, Poland and Spain
Abstract
Authors
P McEwan C Harrison A Cohen-Solal LH Lund M Ohlsson S von Haehling J Comin-Colet DA Pascual-Figal P Ponikowski S Wächter F Dorigotti A Ramirez de Arellano Serna EA Jankowska